Vascular retardation in dormant growth-stunted malignant melanomas

International Journal of Molecular Medicine

Volumn 4, Issue 4, 1999, Pages 403-406

  Pierard Franchimont C ^a   Henry, F ^a   Heymans, O ^a   Pierard G E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Cutaneous melanoma; Vasculature

Indexed keywords

ULEX EUROPAEUS AGGLUTININ; ULEX EUROPAEUS AGGLUTININ 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CORRELATIONAL STUDY; CUTANEOUS MELANOMA; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MIDDLE AGED; PRIMARY CUTANEOUS MELANOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN SURFACE; SURFACE AREA; TUMOR VOLUME; CELL COUNT; IMAGE PROCESSING; MELANOMA; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SKIN TUMOR; VASCULARIZATION;

ADULT; CELL COUNT; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; SKIN NEOPLASMS;

EID: 0033208648     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.4.4.403     Document Type: Article

References (32)

1. Burton RC and Armstrong BK: Current melanoma epidemic: a non-metastasizing form of melanoma? World J Surg 19: 330-333, 1995.
2. MacKie R, Hunter JAA and Aitchison TC: Cutaneous malignant melanoma, Scotland 1979-89. Lancet 339: 971-975, 1992.
3. Burton RC and Armstrong BK: Recent incidence trends imply a non-metastasising form of invasive melanoma. Melanoma Res 4: 107-113, 1994.
4. Guerry D, Synnestvedt M, Elder DE and Schultz D: Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J Invest Dermatol 100: S342-S345, 1993.
5. Piérard GE, Piérard-Franchimont C, Henry C and Lapière M: The proliferative activity of cells of malignant melanomas. Am J Dermatopathol 6: S317-S323, 1984.
6. Smolle J, Hofmann-Wellenhof R and Kerl H: Prognostic significance of proliferation and motility in primary malignant melanoma of the skin. J Cutan Pathol 19: 110-115, 1992.
7. Piérard GE: Melanophagic dermatitis and panniculitis. A condition revealing an occult metastatic malignant melanoma. Am J Dermatopathol 10: 133-136, 1988.
8. Blessing K and McLaren KM: Histological regression in primary cutaneous melanoma: recognition, prevalence and significance. Histopathology 20: 315-322, 1992.
9. Brogelli L, Reali UM, Moretti S and Urso C: The prognostic significance of histologic regression in cutaneous melanoma. Melanoma Res 2: 87-91, 1992.
10. Barnhill RL and Levy MA: Regressing thin cutaneous malignant melanomas (less than or equal to 1. 0 mm) are associated with angiogenesis. Am J Pathol 143: 99-104, 1993.
11. Murray C: Tumour dormancy: not so sleepy after all. Nat Med 1:117-118, 1995.
12. Holmgren L, O'Reilly MS and Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1: 149-153, 1995.
13. Fidler IJ: Critical determinants of melanoma metastasis. J Invest Dermatol Symp Proc 1: 203-208, 1996.
14. Kerbel RS: Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv Cancer Res 55: 87-132, 1990.
15. Kerbel RS, Kobayashi H, Graham CH and Lu C: Analysis and significance of the malignant eclipse during the progression of primary cutaneous human melanomas. J Invest Dermatol Symp Proc 1: 183-187, 1996.
16. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
17. Piérard GE and Piérard-Franchimont C: Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas. Eur J Cancer 33: 1888-1892, 1997.
18. Piérard-Franchimont C and Piérard GE: Apport de la morphométrie et de la biopsie de surface au dépistage du mélanome malin. Rev Med Liege 44: 610-614, 1989.
19. Bourguignon JP, Piérard GE, Ernould C, Heinrichs C, Craen M, Rocchiccioli P, Arrese JE and Franchimont C: Effects of human growth hormone therapy on melanocytic naevi. Lancet 341: 1505-1506, 1993.
20. Piérard GE and Piérard-Franchimont C: Evaluation morphométrique de la croissance de naevus. Ann Dermatol Venereol 120: 605-609, 1993.
21. Piérard GE, Piérard-Franchimont C, Arrese Estrada J, Delvoye P, Henry C, Damseaux M, Le T, Hermanns JF, Letot B, Melotte P, van Cauwenberge D, Ben Mosbah T and Gharbi R: Cyanoacrylate skin surface strippings as an improved approach for distinguishing dysplastic ne vi from malignant melanomas. J Cutan Pathol 16: 180-182, 1989.
22. Piérard GE, Ezzine-Sebai N, Fazaa B, Nikkels-Tassoudji N and Piérard-Franchimont C: Karyometry of malignant melanoma cells present in skin strippings. Skin Res Technol 1: 177-179, 1995.
23. Weibel ER: Practical methods for biological morphometry. In: Stereological Methods. Vol. 1. Academic Press, London, ppl31-155, 1979.
24. Marcoval J, Moreno A, Graells J, Vidal A, Escriba JM, Garcia-Ramiez M and Fabra A: Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase. J Cutan Pathol 24: 212-218, 1997.
25. Retsas S: Systemic treatment of malignant melanoma: grade is as important as stage. Clin Exp Dermatol 22: 67-71, 1997.
26. Srivastava A, Laidler P, Davies RP, Horgan K and Hughes LE: The prognostic significance of tumor vascularity in intermediatethickness (0. 76-4. 0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 133: 419-423, 1988.
27. Carnochan P, Briggs JC, Westbury G and Davies AJ: The vascularity of cutaneous melanoma - a quantitative histological study of lesions 0. 85-1. 25 mm in thickness. Br J Cancer 64: 102-107, 1991.
28. Fallowfield ME and Cook MG: The vascularity of primary cutaneous melanoma. J Pathol 164: 241-244, 1991.
29. Barnhill RL, Fandrey K, Levy MA, Mihm MJ and Hyman B: Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest 67: 331-337, 1992.
30. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS and White WL: Extent of vascularization as a prognostic indicator in thin (<0. 76 mm) malignant melanomas. Am J Pathol 145: 510-514, 1994.
31. Busam KJ, Berwick M and Blessing K: Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 147: 1049-1056, 1995.
32. Elder DE, van Belle P and Elenitsas R: Neoplastic progression and prognosis in melanoma. Semin Cutan Med Surg 15: 336-348, 1996.